Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study.
- Resource Type
- Article
- Source
- Human Vaccines & Immunotherapeutics; 2018, Vol. 14 Issue 12, p2921-2931, 11p
- Subject
- Language
- ISSN
- 21645515